Italy· 051622025
ANZUPGO*crema derm 60 g 20 mg/g
A delgocitinib product containing delgocitinib, registered in Italy by LEO PHARMA A/S, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Delgocitinib is registered in 15 of 19 countries.
Countries holding a registration under ATC D11AH11 (delgocitinib), each read from that country’s own register.
- This record: Italy
- 10 of them publish a price we can compare per daily dose
Delgocitinib · ATC D11AH11
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
- Active substance
- Delgocitinib
- Manufacturer
- LEO PHARMA A/S
- Country
- Italy (IT)
- ATC code
- D11AH11
- ATC class
- Delgocitinib
- Defined daily dose
- 40 mg, T
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic051622025ANZUPGO*crema derm 60 g 20 mg/gEUR 1042.64
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Delgocitinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaANZUPGOLEO Pharma A/S, Ballerup
- NorwayAnzupgoLEO
- United StatesAnzupgoLEO Pharma, Inc
- FinlandAnzupgoLeo Pharma A/S
- FranceANZUPGO 20 mg/g, crèmeLEO PHARMA A/S (DANEMARK)
- United KingdomAnzupgo 20mg/g creamLEO Pharma
- BelgiumAnzupgo 20 mg/gLeo Pharma
- IcelandAnzupgoLEO Pharma A/S*
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Anzupgo
- Iceland · Anzupgo
- Liechtenstein · Anzupgo
- Norway · Anzupgo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ae2d542a-61b7-4465-ae96-65dfedb6a2ce GET /v1/drugs/ae2d542a-61b7-4465-ae96-65dfedb6a2ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 1042.64,
"source": "aifa",
"currency": "EUR",
"strength": "DELGOCITINIB 60 G 20 MG/G USO ESTERNO",
"substance": "Delgocitinib",
"equivalence_group": "UZM",
"transparency_flag": null
}See everything about delgocitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.